In mice, TICE has been shown to be stimulated by a hydrophilic bile acid pool, resulting in increased fecal neutral sterol loss and reduced plasma cholesterol levels. We investigated whether treatment ...

Ipsen has received the UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for its Elafibranor (Iqirvo) ...

UK MHRA grants marketing approval for Ipsen’s elafibranor to treat adults with rare liver disease known as PCB: United Kingdom Thursday, October 10, 2024, 15:00 Hrs [IST] The Me ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved elafibranor (Iqirvo) to treat adult patients with a rare type of liver disease known as primary biliary cholangitis ...

Ipsen’s Iqirvo (elafibranor) has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to treat ...

Alcoholic hepatitis is a severe form of alcohol-related liver injury and one of the most frequent liver presentations seen by acute medical services. The condition typically affects young and ...

PBC is a type of chronic liver disease in which the small bile ducts in the liver become injured and inflamed and are ...

There's been another twist to the tale of Advanz Pharma's efforts to keep its primary biliary cholangitis (PBC) therapy Ocaliva on the market in the EU. Earlier this week, the European Commission ...

who do not respond or are intolerant to standard first-line therapy with ursodeoxycholic acid (UDCA), with a decision due by 14th August. Out of 99 patients from seladelpar studies who have been ...

NAINR. 2012;12(4):187-201.